A 65-year-old woman with chronic stable angina controlled on amlodipine 5 mg daily and isosorbide mononitrate 40 mg once daily presents with increasing frequency of anginal episodes (now 4–5 times per week despite medication). She denies dyspnea, orthopnea, or lower limb edema. BP is 130/80 mmHg, HR 72/min, and echocardiography shows normal left ventricular function. What is the most appropriate next step in management?

Explanation

## Clinical Scenario Analysis This patient has **progressive stable angina** (increasing frequency despite dual antianginal therapy) with preserved left ventricular function. The goal is to add a third antianginal agent and optimize the nitrate regimen to prevent tolerance. ## Pathophysiology of Nitrate Tolerance **Key Point:** Continuous nitrate exposure depletes sulfhydryl donors (cysteine, glutathione) required for bioconversion of organic nitrates to nitric oxide (NO). This leads to loss of vasodilatory effect. **High-Yield:** Prevention of nitrate tolerance requires a **nitrate-free interval of 10–14 hours daily**. Once-daily isosorbide mononitrate (given in the morning) naturally provides this interval, but if angina worsens, escalation requires adding a non-nitrate antianginal agent. ## Optimal Next Step: Add Beta-Blocker ### Rationale: 1. **Beta-blockers are first-line add-on therapy** when CCB monotherapy is insufficient 2. **Reduce myocardial oxygen demand** via decreased heart rate, contractility, and blood pressure 3. **Synergistic with CCB** — no contraindication (amlodipine is a dihydropyridine, which does not cause AV block) 4. **Ensure nitrate-free interval** — maintain isosorbide mononitrate 40 mg once daily (morning) to prevent tolerance; do NOT increase dose 5. **Long-acting formulation** — provides sustained antianginal effect throughout the day ## Why NOT the Other Options? | Option | Problem | |--------|----------| | Increase amlodipine alone | Already on adequate CCB dose; adding sublingual GTN only treats acute episodes, not prevention | | Switch to isosorbide dinitrate | Dinitrate requires twice-daily dosing and does not inherently prevent tolerance; still needs nitrate-free interval | | Increase mononitrate to 60 mg | Increases risk of nitrate tolerance by reducing the nitrate-free interval; monotherapy escalation is less effective than adding a second agent | | Add second CCB | Redundant; two CCBs do not provide additional benefit and increase adverse effects (hypotension, reflex tachycardia) | **Clinical Pearl:** The combination of a long-acting beta-blocker + CCB + long-acting nitrate (with nitrate-free interval) is the gold standard for stable angina refractory to dual therapy. This triple-drug regimen addresses all three mechanisms of angina: increased preload, increased contractility, and increased afterload. **Mnemonic — Antianginal Classes & Mechanisms (BCNB):** - **B**eta-blockers: ↓ HR, ↓ contractility, ↓ BP - **C**alcium channel blockers: ↓ BP, ↓ HR (non-DHP), vasodilation - **N**itrates: vasodilation, ↓ preload - **B**lood pressure control: all three classes reduce myocardial O₂ demand **Tip:** In NEET PG, when a patient on dual antianginal therapy (CCB + nitrate) has worsening angina, the next step is ALWAYS to add a beta-blocker (if not contraindicated) and ensure nitrate-free interval. Do not escalate monotherapy; add a new class. [cite:Harrison 21e Ch 297]